Hervé Guillard

This inventor holds 39 USPTO granted patents and 12 published patent applications, primarily in Pharmaceutical Formulations. Top assignee: Flamel Ireland Limited. Active years: 2019-2026.

USPTO Granted Patents = 39 (Patent Applications = 12)

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 16

Forward Citations = 711(Granted Patents)

Company Filing History:

39 out of 59

Flamel Ireland Limited

patents

Years Active: 2019-2026

Loading Chart...

Areas of Expertise:

Gamma-Hydroxybutyrate

Pharmacokinetics

Modified Release

Formulations

Administration Methods

High-Fat Meal

Drug Delivery

Bioavailability

Therapeutics

Controlled Release

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12728110 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2026-09-08),

2. 12551457 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2026-02-17),

3. 12478604 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-11-25),

4. 12295926 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-05-13),

5. 12263151 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-04-01),

6. 12263150 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-04-01),

7. 12257223 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-03-25),

8. 12239625 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-03-04),

9. 12226389 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-02-18),

10. 12226388 - Modified release gamma- hydroxybutyrate formulations having improved pharmacokinetics (2025-02-18),

11. 12186298 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-01-07),

12. 12186296 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-01-07),

13. 12144793 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2024-11-19),

14. 12138239 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2024-11-12),

15. 12128021 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2024-10-29),

Title: Inventor Hervé Guillard

Introduction: Hervé Guillard is a renowned inventor based in Villeurbanne, France, known for his groundbreaking contributions to various fields.

Latest Patents: Hervé Guillard holds several patents in the areas of renewable energy technologies, sustainable materials, and innovative medical devices.

Career Highlights: Throughout his career, Hervé Guillard has been recognized for his innovative solutions that have significantly impacted industries such as healthcare, environmental sustainability, and technology.

Collaborations: Hervé Guillard has collaborated with leading research institutions, universities, and companies worldwide to bring his inventions to life and make a positive difference in the world.

Conclusion: Hervé Guillard's passion for innovation and dedication to creating impactful solutions have solidified his reputation as a pioneering inventor in Villeurbanne, France.